Atlas Trials

Efficacy of Dapagliflozin in Diabetes Associated Peripheral Neuropathy

Clinical trial NCT05162690 · UNKNOWN

Trial details

NCT number
NCT05162690
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Diabetic Peripheral Neuropathy
Start date
2022-05-01
Primary completion
2023-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.